MONTREAL, Sept. 14, 2011 /CNW Telbec/ - Maisonneuve-Rosemont Hospital
(HMR) announces the acquisition of new medical equipment that would
help solve a major problem with regard to knee assessment and
accelerate research progress in this area. The KneeKGTM system was designed by three Quebec universities under the supervision
of the Imaging and Orthopaedics Research Laboratory (LIO) and Emovi
Inc. a Quebec firm.
Precision to the Exact Millimetre and Degree
The KneeKGTM system can precisely assess indiscernible movements of the bones of the
knee. It can therefore be used to detect and measure functional
deficiencies associated with common knee problems. After 12 years of
being in development, this Health Canada approved tool is now available
for Quebec patients in a hospital center.
A Solution that Pushes the Limits of Current Investigation Tools
The aims of this acquisition by HMR are multiple.
Offer tailored treatments meeting the biomechanical needs of each
Since this technology enables to identify biomechanical problems
impossible to see with other tests currently available, the medical
team can therefore better identify the causes of pain and more
precisely guide them in their choice of complementary investigations,
if necessary, and eventual treatments. In certain cases, it's possible
to delay or even avoid surgery because it was possible to steer a
patient toward a front-line treatment and prevent the patient's
condition from worsening.
Reduce the number of medical consultations per patient with medical
This acquisition will enable to evaluate how to better integrate the
functional knee exam in the continuum of care to the benefit of our
health system. The team hopes to prove that the KneeKGTM can reduce costs associated to current investigations and inefficient
use of orthopedic consultations of patients referred by the front-line.
Eliminate costly, not easily available exams such as magnetic resonance.
By simplifying the diagnosis and management of patients with a knee
pathology, the KneeKGTM could help better understand or explain the patient's symptoms and when
current diagnostic tools, such as magnetic resonance and X-Rays are
Giving Back a Natural Knee to Osteoarthrosic Patients
Between 1998 and 2008*, the number of total knee replacement surgeries
carried out in Canada increased at an exponential rate. Patients are
increasingly young and want to remain active after their surgery.
Often, however, current implants and surgery techniques do not allow
the knee to regain its initial level of functionality. "Implants currently available are made to fit all patients despite that
each person has a different anatomy and different function. The KneeKGTM is a unique tool that will allow to better understand the problems of
current joint- replacement procedures and could help develop more
efficient prosthesis,", stated Dr. Pascal André Vendittoli, orthopedic surgeon at the HMR and
Research Director in the Orthopedic Division at the University of
Maisonneuve-Rosemont Hospital: a Worldwide Precursor
HMR's orthopedic research team is the first in the world to acquire the
KneeKGTM system. Over the past several years, Dr. Pascal André Vendittoli and Dr.
Martin Lavigne have positioned themselves as leaders in Canada and
internationally in assessment and development of new technologies in
hip and knee arthroplasty. This new KneeKGTM system and partnership with the LIO shall be major assets to help their
research work evolve. HMR's vision consists in integrating current
knowledge and innovative technologies, such as the KneeKGTM system, to better meet patient needs. For the Emovi firm, that has
completed the development of the KneeKGTM and owns the commercialization licence, the acquisition of the system
by HMR is an eloquent endorsement that proves the revolutionary aspect
of this diagnostic aid tool.
About Maisonneuve-Rosemont Hospital
Affiliated to the University of Montreal, Maisonneuve-Rosemont Hospital
is a major institution where healthcare, teaching and medical research
converge. Its 5,500 employees and doctors work with the population from
the Greater Montreal Area and beyond since the hospital has a
supra-regional vocation. HMR houses a major research centre. Three axes
stand out both nationally and internationally, Vision Health,
Immunology-Oncology, and Nephrology. Every year it welcomes over 4,000
students, futures doctors, nurses and health professionals.
About the Imaging and Orthopedics Research Laboratory (LIO)
The Imaging and Orthopedics Research Laboratory (LIO) is associated with
the "Musculoskeletal" and "Cardio-metabolic" research themes and the
Imaging Research Platform of the CHUM Research Center (CRCHUM) as well
as affiliated with the École de technologie supérieure. The LIO
continues its mission in research and development in various
cutting-edge health care areas associated with medical imagery and
musculoskeletal system assessment with applications in the fields of
orthopedics, physiatry, and rheumatology and endovascular biometrics.
Emovi is a Quebec business offering medical solutions for the knee
joint. In partnership with the Quebec university research environment,
among which the CRCHUM and École de technologie supérieure (ÉTS), Emovi
completed the development of the KneeKGTM, a unique clinical tool in the world. Emovi owns the exclusive licence
to commercialize the KneeKGTM and has launched its commercialization in Canada, the United States and
Europe. Emovi hopes to broaden access to this technology to contribute
to improving the quality of life of people struggling with diseases
such as knee arthritis, ligament or meniscus tears, patellofemoral
syndrome, tendonitis and biomechanical deficiencies causing pain and
*Source: Canadian Institute for Health Information.
SOURCE HOPITAL MAISONNEUVE-ROSEMONT
For further information:
Christine Lussier, Conseillère-cadre aux communications